September 20th, 2012
Why I Applaud the Skeptical Physicians
Joseph S. Ross, MD, MHS
Is skepticism of industry-funded trials warranted even when they are designed, conducted, and reported with the utmost rigor?
March 27th, 2012
Statistical Pitfalls: The Onus is on Us to Look at the Evidence
Jeremiah Depta, MD
Light, not just heat, is generated in a highly animated and entertaining session on how to interpret research data.
January 26th, 2012
Sizing Up Clinical Trials — Quickly and Intuitively
John E Brush, MD
A pharmaceutical sales rep comes to your office bringing lunch. He shows you a graphic stating that Multaq (dronedarone) reduced the primary endpoint in the ATHENA trial by 24%. The fine print shows an impressive P value: <0.0001. You come away satisfied that this drug looks good. You may not realize it, but you also […]
NEJM Journal Watch — Recent Cardiology Articles- Preventive PCI of Vulnerable Plaques Linked to Fewer Cardiac Events
- News from the ACC Scientific Sessions 2024
- Does the Coronary Sinus Reducer Decrease Ischemia and Angina in Patients with Stable Coronary Disease?
- Plozasiran Reduced Triglyceride Levels in Severe Hypertriglyceridemia
- Managing Elevated Blood Pressure in Hospitalized Patients